EPHA2 and cancer: The use of physical barriers to interfere with EphA2 receptor-ephrinA1 ligand binding, clustering and subsequent lateral transport results in changes to the cellular response of EphA2 to ephrinA1 in cancer cells [336] (Figure 3).